Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO₂ Laser Plus Topical Metformin for Acanthosis Nigricans
NCT07760181Phase 1Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Aug 2026
- Primary completion
- Aug 2027
01
Overview
Phase 1, single-arm trial of metformin 1% gel in acanthosis nigricans, sponsored by Al-Azhar University. Primary endpoint: Acanthosis Nigricans Area and Severity Index. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
metformin 1% gel
03
Conditions
acanthosis nigricans
Beyond the preview
Go deeper on NCT07760181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07760181.